210 related articles for article (PubMed ID: 2019464)
21. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of flow cytometry for metastatic potential in breast cancer.
Schmidt H; Wei JP; Yeh KA
Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
[TBL] [Abstract][Full Text] [Related]
23. Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Eur Surg Res; 1992; 24(3):160-8. PubMed ID: 1499604
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: classical and random mitotic activity assessments with correction for volume percentage of epithelium.
Jannink I; van Diest PJ; Baak JP
Hum Pathol; 1995 Oct; 26(10):1086-92. PubMed ID: 7557941
[TBL] [Abstract][Full Text] [Related]
25. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Jonsson H
Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.
Bergers E; Baak JP; van Diest PJ; Willig AJ; Los J; Peterse JL; Ruitenberg HM; Schapers RF; Somsen JG; van Beek MW; Bellot SM; Fijnheer J; van Gorp LH
Mod Pathol; 1997 Aug; 10(8):762-8. PubMed ID: 9267817
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients.
Lewis WE
Cancer; 1990 May; 65(10):2315-20. PubMed ID: 2346915
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of cells with more than 5c DNA content in node-negative breast cancer as determined by image cytometry from tissue sections.
Siitonen SM; Kallioniemi OP; Helin HJ; Isola JJ
Hum Pathol; 1993 Dec; 24(12):1348-53. PubMed ID: 8276382
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy.
Michels JJ; Duigou F; Marnay J; Denoux Y; Delozier T; Chasle J
Cytometry B Clin Cytom; 2003 Sep; 55(1):37-45. PubMed ID: 12949958
[TBL] [Abstract][Full Text] [Related]
31. Syntactic structure analysis in invasive breast cancer: analysis of reproducibility, biologic background, and prognostic value.
van Diest PJ; Fleege JC; Baak JP
Hum Pathol; 1992 Aug; 23(8):876-83. PubMed ID: 1644433
[TBL] [Abstract][Full Text] [Related]
32. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage.
Marcus JN; Watson P; Page DL; Narod SA; Lenoir GM; Tonin P; Linder-Stephenson L; Salerno G; Conway TA; Lynch HT
Cancer; 1996 Feb; 77(4):697-709. PubMed ID: 8616762
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the prognostic value of morphometric features and cellular DNA content in FIGO I ovarian cancer patients.
Baak JP; Wisse-Brekelmans EC; Uyterlinde AM; Schipper NW
Anal Quant Cytol Histol; 1987 Aug; 9(4):287-90. PubMed ID: 3663312
[TBL] [Abstract][Full Text] [Related]
34. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
[TBL] [Abstract][Full Text] [Related]
35. Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.
Baak JP; Colpaert CG; van Diest PJ; Janssen E; van Diermen B; Albernaz E; Vermeulen PB; Van Marck EA
Eur J Cancer; 2005 Sep; 41(14):2093-101. PubMed ID: 16153819
[TBL] [Abstract][Full Text] [Related]
36. The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.
Toikkanen S; Joensuu H; Klemi P
Br J Cancer; 1989 Nov; 60(5):693-700. PubMed ID: 2553094
[TBL] [Abstract][Full Text] [Related]
37. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
[TBL] [Abstract][Full Text] [Related]
38. Hypoploidy defines patients with poor prognosis in breast cancer.
Chavez-Uribe E; Cameselle-Teijeiro J; Viñuela JE; Castro-Piñeiro C; Gude F; Forteza J; Puente-Domínguez JL
Oncol Rep; 2007 May; 17(5):1109-14. PubMed ID: 17390052
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of a morphometric prognostic index in female breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Oncology; 1993; 50(1):57-62. PubMed ID: 8421599
[TBL] [Abstract][Full Text] [Related]
40. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]